Macro Group Pharmaceuticals (Macro Capital) S.A.E (EGX:MCRO)
1.420
-0.010 (-0.70%)
At close: Nov 12, 2026
| Market Cap | 4.86B +162.2% |
| Revenue (ttm) | 1.06B +36.3% |
| Net Income | 131.22M +9.7% |
| EPS | 0.08 -62.7% |
| Shares Out | 3.42B |
| PE Ratio | 18.15 |
| Forward PE | 20.29 |
| Dividend | 0.11 (7.52%) |
| Ex-Dividend Date | n/a |
| Volume | 25,684,061 |
| Open | 1.430 |
| Previous Close | 1.430 |
| Day's Range | 1.400 - 1.440 |
| 52-Week Range | 0.808 - 3.450 |
| Beta | 0.21 |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Nov 15, 2026 |